Trials / Conditions / Transformed Follicular Lymphoma
Transformed Follicular Lymphoma
5 registered clinical trials studyying Transformed Follicular Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T NCT04488354 | Calibr, a division of Scripps Research | Phase 1 |
| Completed | CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies NCT04450069 | Calibr, a division of Scripps Research | Phase 1 |
| Completed | Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma NCT04833504 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone NCT01897571 | Epizyme, Inc. | Phase 1 / Phase 2 |
| Completed | MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincrist NCT01397825 | Millennium Pharmaceuticals, Inc. | Phase 1 / Phase 2 |